Search

Author/Creator Ferrante, Marc

1. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Issue 8 (10th September 2013)

Authors:
Machiels, Kathleen; Joossens, Marie; Sabino, João; De Preter, Vicky; Arijs, Ingrid; Eeckhaut, Venessa; Ballet, Vera; Claes, Karolien; Van Immerseel, Filip; Verbeke, Kristin; Ferrante, Marc; Verhaegen, Jan; Rutgeerts, Paul; Vermeire, Séverine
Journal:
Gut
Issue:
Volume 63:Issue 8(2014)
Page Start:
1275
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Population Pharmacokinetic and Exposure–Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis. Issue 4 (2nd August 2019)

Authors:
Dreesen, Erwin; Kantasiripitak, Wannee; Detrez, Iris; Stefanović, Sebastian; Vermeire, Séverine; Ferrante, Marc; Bouillon, Thomas; Drobne, David; Gils, Ann
Journal:
Inflammatory bowel diseases
Issue:
Volume 26:Issue 4(2020)
Page Start:
570
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A Population Pharmacokinetic and Exposure–Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis. Issue 4 (4th March 2020)

Authors:
Dreesen, Erwin; Kantasiripitak, Wannee; Detrez, Iris; Stefanović, Sebastian; Vermeire, Séverine; Ferrante, Marc; Bouillon, Thomas; Drobne, David; Gils, Ann
Journal:
Inflammatory bowel diseases
Issue:
Volume 26:Issue 4(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Adalimumab versus ustekinumab as first-line biological in moderate-to-severe Crohn's disease: real-life cohort from a tertiary referral center. Issue 10 (30th August 2022)

Authors:
Moens, Annick; Alsoud, Dahham; Verstockt, Bram; Sabino, João; Ferrante, Marc; Vermeire, Séverine
Journal:
European journal of gastroenterology & hepatology
Issue:
Volume 34:Issue 10(2022)
Page Start:
1015
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial. Issue 7 (10th April 2015)

Authors:
Baert, Filip; Kondragunta, Venkateswarlu; Lockton, Steven; Vande Casteele, Niels; Hauenstein, Scott; Singh, Sharat; Karmiris, Konstantinos; Ferrante, Marc; Gils, Ann; Vermeire, Séverine
Journal:
Gut
Issue:
Volume 65:Issue 7(2016)
Page Start:
1126
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗